PMC:7187660 / 504-3058
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 67-75 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 168-176 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 179-188 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 406-414 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 704-726 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T8 | 770-782 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T9 | 826-834 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T10 | 878-897 | Disease | denotes | respiratory disease | http://purl.obolibrary.org/obo/MONDO_0005087 |
T11 | 1048-1056 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 1123-1131 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 1963-1975 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T14 | 2044-2052 | Disease | denotes | Diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T15 | 2118-2140 | Disease | denotes | Cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T16 | 2205-2224 | Disease | denotes | Respiratory disease | http://purl.obolibrary.org/obo/MONDO_0005087 |
T17 | 2287-2293 | Disease | denotes | Cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 109-110 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 236-238 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T6 | 566-570 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
T7 | 566-570 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
T8 | 618-624 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | female |
T9 | 1307-1310 | http://purl.obolibrary.org/obo/CLO_0001414 | denotes | 548 |
T10 | 1382-1384 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T11 | 1812-1816 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | Male |
T12 | 1812-1816 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | Male |
T13 | 1889-1895 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | Female |
T14 | 2225-2228 | http://purl.obolibrary.org/obo/CLO_0001405 | denotes | 511 |
T15 | 2414-2417 | http://purl.obolibrary.org/obo/CLO_0001445 | denotes | 617 |
T16 | 2523-2524 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 2538-2539 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 566-570 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
T2 | 635-637 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T3 | 728-730 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T4 | 836-838 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T5 | 899-901 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T6 | 954-956 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T7 | 1228-1230 | Chemical | denotes | RR | http://purl.obolibrary.org/obo/CHEBI_73811 |
T8 | 2388-2393 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T9 | 2439-2444 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T10 | 2474-2479 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-102 | Sentence | denotes | The basic characteristics between survivors and non-survivors with COVID-19 were presented in Table 1. |
T5 | 103-272 | Sentence | denotes | Among a total of 44,672 patients with laboratory confirmation of SARS-CoV-2 infection, 1023 (2.3%) patients were dead as of February 11, 2020, the last day of follow-up. |
T6 | 273-387 | Sentence | denotes | The fatality rate was increasing with ages and even up to 14.8% in patients aged above 80 years old (see Fig. 1a). |
T7 | 388-535 | Sentence | denotes | The prevalence of COVID-19 between men and women was pretty close (51.4% vs. 48.6%), which is different from previous report (58.1% vs. 41.9%) [3]. |
T8 | 536-690 | Sentence | denotes | Notably, the fatality rate of male patients was significantly higher than that of female patients (RR = 1.67, 95%CI = 1.47–1.89, p < 0.001) (see Fig. 1b). |
T9 | 691-1057 | Sentence | denotes | Furthermore, cardiovascular disease (RR = 6.75, 95%CI = 5.40–8.43, p < 0.001), hypertension (HR = 4.48, 95%CI = 3.69–5.45, p < 0.001), diabetes (RR = 4.43, 95%CI = 3.49–5.61, p < 0.001), respiratory disease (RR = 3.43, 95%CI = 2.42–4.87, p < 0.001), and cancers (RR = 2.926, 95%CI = 1.34–6.41, p = 0.006) were the risk factors for fatality of patients with COVID-19. |
T10 | 1058-1131 | Sentence | denotes | Table 1 Characteristics between survivors and non-survivors with COVID-19 |
T11 | 1132-1240 | Sentence | denotes | Characteristics Total (n = 44,672) Non-survivors (n = 1023) Survivors (n = 43,649) Fatality (%) RR (95%CI) p |
T12 | 1241-1251 | Sentence | denotes | Age, n (%) |
T13 | 1252-1281 | Sentence | denotes | 0– 416 (0.9%) 0 416 (0.9%) 0 |
T14 | 1282-1321 | Sentence | denotes | 10– 549 (1.2%) 1 (0.1%) 548 (1.3%) 0.2 |
T15 | 1322-1363 | Sentence | denotes | 20– 3619 (8.1%) 7 (0.7%) 3612 (8.3%) 0.2 |
T16 | 1364-1408 | Sentence | denotes | 30– 7600 (17.0%) 18 (1.8%) 7582 (17.4%) 0.2 |
T17 | 1409-1453 | Sentence | denotes | 40– 8571 (19.2%) 38 (3.7%) 8533 (19.5%) 0.4 |
T18 | 1454-1502 | Sentence | denotes | 50– 10,008 (22.4%) 130 (12.7%) 9878 (22.6%) 1.3 |
T19 | 1503-1549 | Sentence | denotes | 60– 8583 (19.2%) 309 (30.2%) 8274 (19.0%) 3.6 |
T20 | 1550-1594 | Sentence | denotes | 70– 3918 (8.8%) 312 (30.5%) 3606 (8.3%) 8.0 |
T21 | 1595-1641 | Sentence | denotes | ≥ 80 1408 (3.2%) 208 (20.3%) 1200 (2.7%) 14.8 |
T22 | 1642-1658 | Sentence | denotes | Severity*, n (%) |
T23 | 1659-1707 | Sentence | denotes | Mild/moderate 36,160 (80.9%) 0 36,160 (82.8%) 0 |
T24 | 1708-1745 | Sentence | denotes | Severe 6168 (13.8%) 0 6168 (14.1%) 0 |
T25 | 1746-1796 | Sentence | denotes | Critical 2087 (4.7%) 1023 (100%) 1064 (2.4%) 49.0 |
T26 | 1797-1810 | Sentence | denotes | Gender, n (%) |
T27 | 1811-1887 | Sentence | denotes | Male 22,981 (51.4%) 653 (63.8%) 22,328 (51.2%) 2.8 1.67 (1.47–1.89) < 0.001 |
T28 | 1888-1941 | Sentence | denotes | Female 21,691 (48.6%) 370 (36.2%) 21,321 (48.8%) 1.7 |
T29 | 1942-1961 | Sentence | denotes | Comorbidity#, n (%) |
T30 | 1962-2042 | Sentence | denotes | Hypertension 2683 (12.8%) 161 (39.7%) 2522 (12.3%) 6.0 4.48 (3.69–5.45) < 0.001 |
T31 | 2043-2116 | Sentence | denotes | Diabetes 1102 (5.3%) 80 (19.7%) 1022 (5.0%) 7.3 4.47 (3.49–5.61) < 0.001 |
T32 | 2117-2203 | Sentence | denotes | Cardiovascular disease 873 (4.2%) 92 (22.7%) 781 (3.8%) 10.5 6.75 (5.40–8.43) < 0.001 |
T33 | 2204-2285 | Sentence | denotes | Respiratory disease 511 (2.4%) 32 (7.9%) 479 (2.3%) 6.3 3.43 (2.42–4.87) < 0.001 |
T34 | 2286-2351 | Sentence | denotes | Cancer 107 (0.5%) 6 (1.5%) 101 (0.5%) 5.6 2.93 (1.34–6.41) 0.006 |
T35 | 2352-2394 | Sentence | denotes | *Missing data (n = 257 in survivors group) |
T36 | 2395-2480 | Sentence | denotes | #Missing data (n = 617 in the non-survivors group, n = 23,073 in the survivors group) |
T37 | 2481-2554 | Sentence | denotes | Fig. 1 Fatality rate distribution of age (a) and gender (b). ***p < 0.001 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 704-726 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T2 | 770-782 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T3 | 1963-1975 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T4 | 2118-2140 | Phenotype | denotes | Cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T5 | 2287-2293 | Phenotype | denotes | Cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 67-75 | SP_7 | denotes | COVID-19 |
T7 | 168-178 | SP_7 | denotes | SARS-CoV-2 |
T8 | 406-414 | SP_7 | denotes | COVID-19 |
T9 | 704-718 | UBERON:0004535 | denotes | cardiovascular |
T10 | 878-889 | UBERON:0001004 | denotes | respiratory |
T11 | 1048-1056 | SP_7 | denotes | COVID-19 |
T12 | 1123-1153 | SP_7 | denotes | COVID-19 Characteristics Total |
T13 | 2118-2132 | UBERON:0004535 | denotes | Cardiovascular |
T89898 | 67-75 | SP_7 | denotes | COVID-19 |
T58247 | 168-178 | SP_7 | denotes | SARS-CoV-2 |
T56005 | 406-414 | SP_7 | denotes | COVID-19 |
T25359 | 704-718 | UBERON:0004535 | denotes | cardiovascular |
T45386 | 878-889 | UBERON:0001004 | denotes | respiratory |
T24778 | 1048-1056 | SP_7 | denotes | COVID-19 |
T56769 | 1123-1153 | SP_7 | denotes | COVID-19 Characteristics Total |
T38161 | 2118-2132 | UBERON:0004535 | denotes | Cardiovascular |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
17 | 1963-1975 | Disease | denotes | Hypertension | MESH:D006973 |
18 | 2044-2052 | Disease | denotes | Diabetes | MESH:D003920 |
19 | 2118-2140 | Disease | denotes | Cardiovascular disease | MESH:D002318 |
20 | 2205-2224 | Disease | denotes | Respiratory disease | MESH:D012140 |
21 | 2287-2293 | Disease | denotes | Cancer | MESH:D009369 |
23 | 1123-1131 | Disease | denotes | COVID-19 | MESH:C000657245 |
41 | 127-135 | Species | denotes | patients | Tax:9606 |
42 | 202-210 | Species | denotes | patients | Tax:9606 |
43 | 340-348 | Species | denotes | patients | Tax:9606 |
44 | 423-426 | Species | denotes | men | Tax:9606 |
45 | 431-436 | Species | denotes | women | Tax:9606 |
46 | 571-579 | Species | denotes | patients | Tax:9606 |
47 | 625-633 | Species | denotes | patients | Tax:9606 |
48 | 1034-1042 | Species | denotes | patients | Tax:9606 |
49 | 67-75 | Disease | denotes | COVID-19 | MESH:C000657245 |
50 | 168-188 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
51 | 406-414 | Disease | denotes | COVID-19 | MESH:C000657245 |
52 | 704-726 | Disease | denotes | cardiovascular disease | MESH:D002318 |
53 | 770-782 | Disease | denotes | hypertension | MESH:D006973 |
54 | 826-834 | Disease | denotes | diabetes | MESH:D003920 |
55 | 878-897 | Disease | denotes | respiratory disease | MESH:D012140 |
56 | 945-952 | Disease | denotes | cancers | MESH:D009369 |
57 | 1048-1056 | Disease | denotes | COVID-19 | MESH:C000657245 |